1. Home
  2. ARWR vs GMED Comparison

ARWR vs GMED Comparison

Compare ARWR & GMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arrowhead Pharmaceuticals Inc.

ARWR

Arrowhead Pharmaceuticals Inc.

BUY

Current Price

$61.29

Market Cap

12.4B

Sector

Health Care

ML Signal

BUY

Logo Globus Medical Inc.

GMED

Globus Medical Inc.

BUY

Current Price

$73.55

Market Cap

11.0B

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
ARWR
GMED
Founded
2003
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.4B
11.0B
IPO Year
2009
2012

Fundamental Metrics

Financial Performance
Metric
ARWR
GMED
Price
$61.29
$73.55
Analyst Decision
Strong Buy
Buy
Analyst Count
14
15
Target Price
★ $107.23
$100.92
AVG Volume (30 Days)
★ 2.1M
1.5M
Earning Date
11-24-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
99.80
★ 422.67
EPS
N/A
★ 2.00
Revenue
$16,142,321.00
★ $2,938,931,000.00
Revenue This Year
N/A
$8.87
Revenue Next Year
N/A
$6.04
P/E Ratio
★ N/A
$38.15
Revenue Growth
N/A
★ 16.65
52 Week Low
$34.61
$56.52
52 Week High
$95.49
$101.40

Technical Indicators

Market Signals
Indicator
ARWR
GMED
Relative Strength Index (RSI) 26.63 39.47
Support Level $60.87 N/A
Resistance Level $66.37 $82.23
Average True Range (ATR) 2.53 1.65
MACD -0.36 0.31
Stochastic Oscillator 6.54 8.92

Price Performance

Historical Comparison
ARWR
GMED

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.

About GMED Globus Medical Inc.

Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.

Share on Social Networks: